Literature DB >> 25673187

Association of IL33/ST2 signal pathway gene polymorphisms with myocardial infarction in a Chinese Han population.

Jin-Hua Yang1, Fang-Qin Wu1, Qiang Wen1, Wen-Cai Zhang1, Yang-E Wang1, Xin Xiong1, Yan-Wen Su1, Long-Xian Cheng2,3.   

Abstract

This study investigated the relationship between IL-33/ST2 signal pathway gene polymorphisms and myocardial infarction (MI) in Han Chinese. A case-control association analysis was performed on a total of 490 MI patients (MI group) and 929 normal subjects (NC group). Sequenom Mass Array and Taqman genotyping technique were used to analyze the tag single nucleotide polymorphisms (SNPs) in the genes encoding IL-33, ST2, and IL-1RaP (rs11792633, rs1041973 and rs4624606). The results showed that the frequencies of rs4624606 genotypes AA, TT, AT were 0.031, 0.647, 0.322 in MI group and 0.026, 0.712, 0.263 in NC group, and the allele frequencies of A and T were 0.192, 0.808 in MI group and 0.157, 0.843 in NC group. There were significant differences in rs4624606 genotypes and allele frequencies between MI group and NC group (P<0.05). For rs11792633, the allele frequencies of C and T were 0.45, 0.55 in MI group and 0.454, 0.546 in NC group with no significant differences found between the two groups. Compared with genotype CC+TC, rs11792633 genotype TT had an increased risk of hypertension (P<0.05). However, there were no significant differences in the frequencies of rs11792633 genotypes between the two groups. No significant differences were noted in the frequencies of rs1041973 genotype and allele between the two groups. Logistic regression analysis showed that rs4624606 genotypes AT and AA+AT were both significantly associated with MI (AT: OR=1.325, P=0.029, 95% CI=1.03-1.705; AA+AT: OR=1.316, P=0.028, 95% CI=1.03-1.681) after factors such as age, gender, smoking, drinking, body mass index (BMI), triglyceride (TG) and cholesterol were adjusted. Those carrying rs4624606 genotype AT or AA+AT had an increased risk of MI. No associations were found between the polymorphisms of the other two loci with MI. It was concluded that, in the IL33/ST2 signal pathway, the A allele of rs4624606 polymorphism of IL-1RaP gene is a potential independent risk factor for MI, and the genotypes AA+AT and AT are associated with the incidence of MI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25673187     DOI: 10.1007/s11596-015-1382-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  23 in total

1.  Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.

Authors:  Ellen O Weinberg; Masahisa Shimpo; Gilles W De Keulenaer; Catherine MacGillivray; Shin-ichi Tominaga; Scott D Solomon; Jean-Lucien Rouleau; Richard T Lee
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production.

Authors:  Yeon-Sook Choi; Hyun-Jung Choi; Jeong-Ki Min; Bo-Jeong Pyun; Yong-Sun Maeng; Hongryeol Park; Jihye Kim; Young-Myeong Kim; Young-Guen Kwon
Journal:  Blood       Date:  2009-08-06       Impact factor: 22.113

4.  The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Han population.

Authors:  Xin Tu; Shaofang Nie; Yuhua Liao; Hongsong Zhang; Qian Fan; Chengqi Xu; Ying Bai; Fan Wang; Xiang Ren; Tingting Tang; Ni Xia; Sisi Li; Yuan Huang; Juan Liu; Qing Yang; Yuanyuan Zhao; Qiulun Lv; Qingxian Li; Yue Li; Yunlong Xia; Jin Qian; Bin Li; Gang Wu; Yanxia Wu; Yan Yang; Qing K Wang; Xiang Cheng
Journal:  Am J Hum Genet       Date:  2013-09-26       Impact factor: 11.025

5.  Identification of serum soluble ST2 receptor as a novel heart failure biomarker.

Authors:  Ellen O Weinberg; Masahisa Shimpo; Shelley Hurwitz; Shin-ichi Tominaga; Jean-Lucien Rouleau; Richard T Lee
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

Review 6.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

7.  IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation.

Authors:  Mariola Kurowska-Stolarska; Bartosz Stolarski; Peter Kewin; Grace Murphy; Christopher J Corrigan; Sun Ying; Nick Pitman; Ananda Mirchandani; Batika Rana; Nico van Rooijen; Malcolm Shepherd; Charlie McSharry; Iain B McInnes; Damo Xu; Foo Y Liew
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

8.  Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.

Authors:  J Chapuis; D Hot; F Hansmannel; O Kerdraon; S Ferreira; C Hubans; C A Maurage; L Huot; F Bensemain; G Laumet; A M Ayral; N Fievet; J J Hauw; S T DeKosky; Y Lemoine; T Iwatsubo; F Wavrant-Devrièze; J F Dartigues; C Tzourio; L Buée; F Pasquier; C Berr; D Mann; C Lendon; A Alpérovitch; M I Kamboh; P Amouyel; J C Lambert
Journal:  Mol Psychiatry       Date:  2009-02-10       Impact factor: 15.992

9.  Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.

Authors:  Marc S Sabatine; David A Morrow; Luke J Higgins; Catherine MacGillivray; Wei Guo; Christophe Bode; Nader Rifai; Christopher P Cannon; Robert E Gerszten; Richard T Lee
Journal:  Circulation       Date:  2008-03-31       Impact factor: 29.690

10.  Associations between variants in IL-33/ST2 signaling pathway genes and coronary heart disease risk.

Authors:  Fangqin Wu; Mei'an He; Qiang Wen; Wencai Zhang; Jinhua Yang; Xiaomin Zhang; Tangchun Wu; Longxian Cheng
Journal:  Int J Mol Sci       Date:  2014-12-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.